Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating expenses:
Research and development	$ 48,260	$ 43,795
General and administrative	14,690	10,591
Total operating expenses	62,950	54,386
Loss from operations	(62,950)	(54,386)
Other income:
Interest income	3,441	2,013
Interest and other expense	(8)	(300)
Total other income (expense)	3,433	1,713
Net loss and comprehensive loss	$ (59,517)	$ (52,673)
Net loss per share attributable to common stockholders: Basic	$ (4.4)	$ (15.28)
Net loss per share attributable to common stockholders: diluted	$ (4.4)	$ (15.28)
Weighted average shares outstanding: Basic	13,515,915	3,447,071
Weighted average shares outstanding: diluted	13,515,915	3,447,071